Potentially Hepatotoxic Botanicals Frequently Used in United States

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Aug. 5, 2024 -- An estimated 15 million U.S. adults consumed at least one of six potentially hepatotoxic botanicals within the previous 30 days, according to a study published online Aug. 5 in JAMA Network Open.

Alisa Likhitsup, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues assessed the prevalence and clinical characteristics of adult consumers of six potentially hepatotoxic botanicals. Data were included for 9,685 adults enrolled between January 2017 and March 2020.

The researchers found that the overall prevalence of herbal and dietary supplement (HDS) product use was 57.6 percent, and the prevalence of use of all six botanicals of interest was 4.7 percent. The most commonly used botanicals were turmeric-containing botanicals (236 adults), followed by products containing green tea, ashwagandha, Garcinia cambogia, red yeast rice, and black cohosh (92, 28, 20, 20, and 19, respectively). Consumers of these six botanicals were significantly older than non-HDS users (adjusted odds ratios, 2.36 and 3.96 for those aged 40 to 59 years and 60 years and older, respectively), and they had a higher education level and were more likely to have arthritis (adjusted odds ratios, 4.78 and 2.27, respectively). At least one of the six botanical products was used within the previous 30 days by an estimated 15,584,599 U.S. adults, which was similar to the estimated number of patients prescribed potentially hepatotoxic drugs, including simvastatin and nonsteroidal anti-inflammatory drugs (14,036,024 and 14,793,837, respectively).

"Considering widespread and growing popularity of botanical products, we urge government authorities to consider increasing the regulatory oversight on how botanicals are produced, marketed, tested, and monitored in the general population," the authors write.

Two authors disclosed ties to the pharmaceutical and/or life science industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-06 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords